Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
In this study 16 Patients diagnosed with Nonarteritic Anterior Ischemic Optic
Neuropathy(NSION) who had a sudden mono ocular vision loss associated with optic disc edema
and positive Marcus Gunn in less than 30 days without exclusion criteria are randomly divided
in two groups 1) control 2) case. In case group Avastin and Triamcinolone will be injected
trough vitreal and placebo will be injected in control group. BCVA and Visual field will be
then measured in these two groups.